Retour
Fourchette du Jour
18,15 €
19,41 €
Fourchette 52 Semaines
16,80 €
29,16 €
Volume
270 490
Moyenne 50J / 200J
19,69 €
/
19,69 €
Clôture Précédente
18,63 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -22,6 | 0,3 |
| P/B | — | 3,0 |
| ROE % | — | 3,7 |
| Net Margin % | -2957,6 | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | — | 0,2 |
Objectif de Cours des Analystes
Hold
31,00 €
+66.3%
BPA Prévisionnel
-0,20 €
CA Est.
62,40M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2026 |
-0,20 €
-0,21 € – -0,19 €
|
62,40M | 1 |
No quarterly estimates available
Earnings Surprises
Last 1 quarter
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-25 | N/A | -60,17 € | — |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Generating 11,90M in free cash flow
Capital intensive — 192,47% of revenue goes to capex
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
N/A
ROICN/A
Net Margin-2957,63%
Op. Margin-3500,34%
Sécurité
Debt / Equity
N/A
Current Ratio15,98
Interest Coverage0,00
Valorisation
P/E Ratio
-22,59
Forward P/EN/A
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1,49M | Net Income (TTM) | -43,98M |
| ROE | N/A | ROA | -13,48% |
| Gross Margin | 100,00% | Operating Margin | -3500,34% |
| Net Margin | -2957,63% | Free Cash Flow (TTM) | 11,90M |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 15,98 |
| Interest Coverage | 0,00 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -22,59 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | 668,09 |
| PEG Ratio | 0,00 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 15,92 | Fwd Earnings Yield | N/A |
| FCF Yield | 1,20% | ||
| Market Cap | 993,46M | Enterprise Value | 968,31M |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Revenue | 1,49M | 0,0 | 0,0 |
| Net Income | -43,98M | -28,64M | -17,93M |
| EPS (Diluted) | 0,00 | 0,00 | 0,00 |
| Gross Profit | 1,49M | 0,0 | 0,0 |
| Operating Income | -52,05M | -34,79M | -19,76M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Total Assets | 326,18M | 122,36M | 138,32M |
| Total Liabilities | 413,98M | 168,66M | 157,55M |
| Shareholders' Equity | -87,80M | -46,31M | -19,23M |
| Total Debt | 12,01M | 13,40M | 1,78M |
| Cash & Equivalents | 37,16M | 29,51M | 128,60M |
| Current Assets | 300,85M | 100,20M | 132,48M |
| Current Liabilities | 18,82M | 6,24M | 5,28M |